Blood and saliva levels of TE-031.
スポンサーリンク
概要
- 論文の詳細を見る
TE-031 is a peroral macrolides antimicrobial agent. This drug belongs to a group of new macrolides which are synthesized from Erythromycin. <I>In vitro</I>, the susceptibility of microorganisms to this drug is the same as Erythromycin, however, it exhibits superior distribution to tissues as well as superior for urinary excretion.<BR>In this study, the blood and saliva concentrations of TE-031 were compared by a crossover test in 10 healthy volunteers who were perorally given 150 mg of this drug while fasting and after a meal.<BR>The distributions of the blood and saliva concentrations show similar patterns for fasting and after a meal. It is suggested that TE-031 is little influenced by food.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果